GlaxoSmithKline Cash Flow Statement
View: Annual
This data is provided as per license from EDGAR Online
| Dec 07 | Dec 06 | Dec 05 | |
|---|---|---|---|
| Net Operating Cash Flow | -- | -- | 9,896.3 |
| Net Investing Cash Flow | -- | -- | (3,171.4) |
| Net Financing Cash Flow | -- | -- | (4,145.4) |
| Net Change in Cash | -- | -- | 2,987.3 |
| Depreciation & Amortization | -- | -- | 1,555.6 |
| Capital Expenditures | -- | -- | (1,553.9) |
| Cash Dividends Paid | -- | -- | (4,260.7) |
This data is provided as per license from EDGAR Online
